Subcutaneous Interferon Beta Therapy in Multiple Sclerosis Patients – Characterization of Injection Site Reactions and Flu-Like Symptoms in a Daily Practice Setting – Results from the Non-Interventional Study PERFECT-Reference-Cited by-同舟云学术

Subcutaneous Interferon Beta Therapy in Multiple Sclerosis Patients – Characterization of Injection Site Reactions and Flu-Like Symptoms in a Daily Practice Setting – Results from the Non-Interventional Study PERFECT

Published:2021-05 Issue: Volume:Volume 15 Page:1091-1100
ISSN:1177-889X
Container-title:Patient Preference and Adherence
language:en
Short-container-title:PPA

Author:

Kukowski Borries,Rehberg-Weber Karin,Taipale Kirsi,Kowalik Andreas,Oschmann Patrick

Publisher

Informa UK Limited

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Social Sciences (miscellaneous),Medicine (miscellaneous)

Reference28 articles.

1. Pharmacokinetic considerations in the treatment of multiple sclerosis with interferon-β

2. Disease-modifying agents in multiple sclerosis

3. The interferon beta therapies for treatment of relapsing–remitting multiple sclerosis: are they equally efficacious? A comparative review of open-label studies evaluating the efficacy, safety, or dosing of different interferon beta formulations alone or in combination

4. PEG-modified biopharmaceuticals

5. PEGylated Interferon Beta-1a: Meeting an Unmet Medical Need in the Treatment of Relapsing Multiple Sclerosis

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of therapy satisfaction with cladribine tablets in patients with RMS: Final results of the non-interventional study CLEVER;Multiple Sclerosis and Related Disorders;2024-10

2. Steigerung der Therapietreue durch niederschwellige Kontakte;Nervenheilkunde;2022-07-28

3. Long-term treatment for multiple sclerosis with interferon beta-1b. Outcomes of an open, retrospective, observational study;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2022